CTT Pharmaceutical Holdings (CTT Pharmaceutical Holdings) Cash-to-Debt : 24.90 (As of Jun. 2018)

View and export this data going back to . Start your Free Trial

What is CTT Pharmaceutical Holdings Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. CTT Pharmaceutical Holdings's cash to debt ratio for the quarter that ended in Jun. 2018 was 24.90.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, CTT Pharmaceutical Holdings could pay off its debt using the cash in hand for the quarter that ended in Jun. 2018.

(1) Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

The historical rank and industry rank for CTT Pharmaceutical Holdings's Cash-to-Debt or its related term are showing as below:

CTTH's Cash-to-Debt is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 0.96
* Ranked among companies with meaningful Cash-to-Debt only.

CTT Pharmaceutical Holdings Cash-to-Debt Historical Data

The historical data trend for CTT Pharmaceutical Holdings's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

CTT Pharmaceutical Holdings Cash-to-Debt Chart

CTT Pharmaceutical Holdings Annual Data

Trend

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Cash-to-Debt

Get a 7-Day Free Trial

No Debt

N/A

No Debt

CTT Pharmaceutical Holdings Quarterly Data
	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Mar17	Jun17	Mar18	Jun18
Cash-to-Debt	Get a 7-Day Free Trial															No Debt	N/A	N/A	No Debt	24.90

Competitive Comparison of CTT Pharmaceutical Holdings's Cash-to-Debt

For the Drug Manufacturers - Specialty & Generic subindustry, CTT Pharmaceutical Holdings's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CTT Pharmaceutical Holdings's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CTT Pharmaceutical Holdings's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where CTT Pharmaceutical Holdings's Cash-to-Debt falls into.

CTT Pharmaceutical Holdings Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

CTT Pharmaceutical Holdings's Cash to Debt Ratio for the fiscal year that ended in Dec. 2015 is calculated as:

CTT Pharmaceutical Holdings had no debt ⁽¹⁾.

CTT Pharmaceutical Holdings's Cash to Debt Ratio for the quarter that ended in Jun. 2018 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	0.996	/	(0	+	0.04)
	=	24.90

CTT Pharmaceutical Holdings (OTCPK:CTTH) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

CTT Pharmaceutical Holdings Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of CTT Pharmaceutical Holdings's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

CTT Pharmaceutical Holdings (CTT Pharmaceutical Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CTT Pharmaceutical Holdings Inc (OTCPK:CTTH) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

1100 – 1111 Melville Street, Vancouver, BC, CAN, V6E 3V6

Website

https://www.cttpharmaceuticals.com

CTT Pharmaceutical Holdings Inc is a development stage company specializing in drug delivery systems technology within the pharmaceutical industry. It focuses on fast-dissolving drug delivery systems through the development of oral delivery thin wafers. The thin wafers are infused with both natural and synthetic cannabis extracts to deliver treatment as an alternative to smoking and ingestion. Its products include Medwafe, Cannawafe, Vetwafe, and others.

Executives